Surgery Partners Inc (SGRY)
25.82
-0.63
(-2.38%)
USD |
NASDAQ |
May 17, 16:00
25.82
0.00 (0.00%)
After-Hours: 20:00
Surgery Partners Enterprise Value: 7.363B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.363B |
| May 16, 2024 | 7.442B |
| May 15, 2024 | 7.521B |
| May 14, 2024 | 7.507B |
| May 13, 2024 | 7.369B |
| May 10, 2024 | 7.460B |
| May 09, 2024 | 7.523B |
| May 08, 2024 | 7.533B |
| May 07, 2024 | 7.610B |
| May 06, 2024 | 7.334B |
| May 03, 2024 | 7.198B |
| May 02, 2024 | 7.257B |
| May 01, 2024 | 7.210B |
| April 30, 2024 | 7.251B |
| April 29, 2024 | 7.227B |
| April 26, 2024 | 7.200B |
| April 25, 2024 | 7.237B |
| April 24, 2024 | 7.321B |
| April 23, 2024 | 7.306B |
| April 22, 2024 | 7.136B |
| April 19, 2024 | 7.109B |
| April 18, 2024 | 7.057B |
| April 17, 2024 | 7.190B |
| April 16, 2024 | 7.221B |
| April 15, 2024 | 7.343B |
| Date | Value |
|---|---|
| April 12, 2024 | 7.427B |
| April 11, 2024 | 7.377B |
| April 10, 2024 | 7.418B |
| April 09, 2024 | 7.587B |
| April 08, 2024 | 7.556B |
| April 05, 2024 | 7.568B |
| April 04, 2024 | 7.518B |
| April 03, 2024 | 7.574B |
| April 02, 2024 | 7.641B |
| April 01, 2024 | 7.751B |
| March 31, 2024 | 7.872B |
| March 28, 2024 | 7.731B |
| March 27, 2024 | 7.745B |
| March 26, 2024 | 7.650B |
| March 25, 2024 | 7.572B |
| March 22, 2024 | 7.475B |
| March 21, 2024 | 7.533B |
| March 20, 2024 | 7.519B |
| March 19, 2024 | 7.461B |
| March 18, 2024 | 7.438B |
| March 15, 2024 | 7.558B |
| March 14, 2024 | 7.594B |
| March 13, 2024 | 7.585B |
| March 12, 2024 | 7.717B |
| March 11, 2024 | 7.700B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.842B
Minimum
Aug 15 2019
9.454B
Maximum
Apr 20 2022
6.590B
Average
7.062B
Median
Enterprise Value Benchmarks
| DaVita Inc | 22.75B |
| Healthcare Services Group Inc | 784.97M |
| Encompass Health Corp | 11.84B |
| The Oncology Institute Inc | 70.12M |
| American Oncology Network Inc | 230.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.40M |
| Revenue (Quarterly) | 717.40M |
| Total Expenses (Quarterly) | 627.00M |
| EPS Diluted (Quarterly) | -0.10 |
| Gross Profit Margin (Quarterly) | 21.65% |
| Profit Margin (Quarterly) | -1.73% |
| Operating Earnings Yield | 13.22% |
| Normalized Earnings Yield | 2.504 |